MURUGAPPAN M, BABU B, SHANKAR V, YUSUF M, & JAWAHAR N. (2025). ROLE OF FDA 483 OBSERVATIONS IN QUALITY MANAGEMENT SYSTEMS: ENHANCING COMPLIANCE AND RISK MANAGEMENT. Asian Journal of Pharmaceutical and Clinical Research, 18(4), 44–51. https://doi.org/10.22159/ajpcr.2025v18i4.54004